KABS Laboratories

Saint-Hubert, Quebec, Canada
Sterile Fill-Finish Lyophilization Oral Solid Dose Inhalation & Nasal Clinical Trial Manufacturing
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: KABS Laboratories

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Saint-Hubert, Quebec, Canada
Website
Modalities
Sterile Fill-Finish, Lyophilization, Oral Solid Dose, Inhalation & Nasal, Clinical Trial Manufacturing
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About KABS Laboratories

KABS Laboratories is a contract development and manufacturing organization (CDMO). Capabilities: Sterile Fill-Finish, Lyophilization, Oral Solid Dose, Inhalation & Nasal, Clinical Trial Manufacturing. 2 manufacturing sites registered with the U.S. FDA. Website: https://kabs.com/en/integrated-pharmaceutical-cdmo/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

KABS Laboratories FDA Inspection History

2024-02
NAI VAI OAI
Date Site Type Observations Classification
2024-02-01
Laboratoires KABS Inc.
Saint-Hubert Company-level
Drug Quality Assurance No No Action Indicated (NAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About KABS Laboratories

How many FDA inspections does KABS Laboratories have on record?
CDMO Signal tracks 1 FDA inspection for KABS Laboratories, sourced from the FDA inspection database. See the full inspection history above.
Has KABS Laboratories received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for KABS Laboratories.
Does KABS Laboratories have a CDMO Signal Score?
Not yet. KABS Laboratories is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating KABS Laboratories for a manufacturing program?
Use the free AI matchmaker to compare KABS Laboratories against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Quality Chemical Laboratories
Wilmington, North Carolina, United States
Clinical Trial Manufacturing, Oral Solid Dose, Sterile Fill-Finish, Lyophilization
UI Pharmaceuticals
Iowa City, Iowa, United States
Sterile Fill-Finish, Lyophilization, Oral Solid Dose, Clinical Trial Manufacturing
PCI Pharma Services
Bedford, NH, United States · Tredegar, United Kingdom
Sterile Fill-Finish, Biologics, Oral Solid Dose, Clinical Trial Manufacturing, Packaging & Labeling
Diamond Animal Health
Des Moines, Iowa, United States
Veterinary, Vaccines, Microbial Fermentation, Viral Antigens, Sterile Fill-Finish, Lyophilization, Non-sterile Liquids, Oral Solid Dose
Hikma (Contract Manufacturing)
United States
Oral Solid Dose, Oral Liquids, Inhalation & Nasal, Sterile Injectables, Lyophilization, Prefilled Syringes, Cytotoxics

Compare KABS Laboratories with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on KABS Laboratories
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.